초회다제내성 결핵의 위험요인 = Risk Factors for Primary Multidrug Resistant Tuberculosis

참고문헌 (Reference)

1 In Murray J, "Textbook of respiratory medicine" 1988

2 Reider HL, "Snider DE Jr. Epidemiology of tuberculosis in the United States. Epidemiol Rev. Epidemio Rev 1989" 79-98,

3 Espinal MA, "Raviglione MC. Standard short-course chemotherapy for drug resistant tuberculosis treatment outcomes in 6 countries." 2537-45, 2000

4 Koziel H, "Pulmonary complications of diabetes mellitus." 65-96, 1995

5 CDC., "Primary multidrug-resistant tuberculosis-Ivanovo Oblast" 661-664, .1999

6 Kessler I, "Mortality experience of diabetic patients:a twenty-six year follow-up study" 51 : 715-, 1971

7 Sasaki A, "Mortality and causes of death in Type 2 diabetic patients a long-term follow-up study in Osaka District"

8 Mahmoudi A, "Iseman MD. Pitfalls in the care of patients with tuberculosis common errors and their association with the acquisition of drug resistance. JAMA 1993" 65-68,

9 Bashar M, "Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service,1987-1997" 120 : 1514-1519, 2001

10 Kim SJ, "Incidence of pulmonary tuberculosis among diabetics." 529-33, 1995

11 Espinal MA, "Global trends in resistance to antituberculosis drugs." 1294-1303, 2001

12 Rsch-Gerdes S, "Epidemiology of resistant tuberculosis in Europe." -18, 1999

13 World Health Organization, ". Anti-tuberculosis drug resistance in the world. Report no. 2 : Prevalence and trends" 220-, 2000